Author:
Mouillac Bernard,Mendre Christiane
Publisher
Springer International Publishing
Reference83 articles.
1. Ala Y, Morin D, Mouillac B et al (1998) Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype. J Am Soc Nephrol 9(10):1861–1872
2. Aronson D, Verbalis JG, Mueller M et al (2011) Short- and long-term treatment of dilutional hyponatraemia with satavaptan, a selective arginine-vasopressin V2 receptor antagonist: the DILIPO study. Eur J Heart Fail 13(3):327–336
3. Auzan RJ, Ventura MA, Clauser E (2005) Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b/V3 receptor by a pharmacological chaperone. J Biol Chem 280(51):42198–42206
4. Bernier V, Bichet DG, Bouvier M (2004a) Pharmacological chaperone action on G protein-coupled receptors. Curr Opin Pharmacol 4(5):528–533
5. Bernier V, Lagacé M, Lonergan M et al (2004b) Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Mol Endocrinol 18(8):2074–2084
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献